Essex Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$14.4M |
| 2 |
Netflix
NFLX
|
+$9.91M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$8M |
| 4 |
Teladoc Health
TDOC
|
+$7.16M |
| 5 |
Ciena
CIEN
|
+$6.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.1M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$10M |
| 3 |
Biogen
BIIB
|
+$8.82M |
| 4 |
Alibaba
BABA
|
+$8.42M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 20.95% |
| 3 | Industrials | 11.87% |
| 4 | Financials | 8.28% |
| 5 | Consumer Discretionary | 8.1% |
Similar funds
Essex Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, Essex Investment Management held 581 positions worth $637M, down 25% from $851M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Essex Investment Management withdrew a net $70.8M in Q4 2018, closing 105 positions and reducing 207 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $5.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Essex Investment Management opened a new position in NVIDIA worth $10.1M.
- Essex Investment Management's largest Q4 2018 buy was NVIDIA: 3,018,520 shares worth $10.1M.
- Essex Investment Management added most to VanEck Junior Gold Miners ETF in Q4 2018, an estimated $8M increase.
- Essex Investment Management's biggest Q4 2018 reduction was Apple, cutting an estimated $10.1M.
- Essex Investment Management fully exited Regeneron Pharmaceuticals in Q4 2018, selling an estimated $5.1M.
- Essex Investment Management's ten largest holdings make up 18% of its $637M portfolio in Q4 2018.
- Essex Investment Management opened 183 new positions and closed 105 in Q4 2018.
- Essex Investment Management's portfolio value fell 25% quarter-over-quarter to $637M.
Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.